Home » OncoMed to Resume Enrollment in Cancer Drug Trials as FDA Lifts Partial Ban
OncoMed to Resume Enrollment in Cancer Drug Trials as FDA Lifts Partial Ban
OncoMed Pharmaceuticals said the FDA lifted a partial hold on patient enrollments for three trials testing its experimental cancer drug, vantictumab.
MedCity News
Upcoming Events
-
07May
-
14May
-
30May